Global Indocyanine Green (CAS 3599-32-4) Market Research Report 2020

Publisher Name :
Date: 21-Jan-2020
No. of pages: 99
Inquire Before Buying

The global Indocyanine Green (CAS 3599-32-4) market is valued at 44 million US$ in 2020 is expected to reach 59 million US$ by the end of 2026, growing at a CAGR of 4.2% during 2021-2026.

This report focuses on Indocyanine Green (CAS 3599-32-4) volume and value at the global level, regional level and company level. From a global perspective, this report represents overall Indocyanine Green (CAS 3599-32-4) market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan etc.

Market Segment Analysis

The research report includes specific segments by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2015 to 2026. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

Segment by Type, the Indocyanine Green (CAS 3599-32-4) market is segmented into

- 25mg

- 50mg

Segment by Application

- Ophthalmology

- Neurosurgery

- Liver Diseases

- Others

Global Indocyanine Green (CAS 3599-32-4) Market: Regional Analysis

The Indocyanine Green (CAS 3599-32-4) market is analysed and market size information is provided by regions (countries). The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type and by Application segment in terms of sales and revenue for the period 2015-2026.

The key regions covered in the Indocyanine Green (CAS 3599-32-4) market report are:

North America

- U.S.

- Canada

Europe

- Germany

- France

- U.K.

- Italy

- Russia

Asia-Pacific

- China

- Japan

- South Korea

- India

- Australia

- Taiwan

- Indonesia

- Thailand

- Malaysia

- Philippines

- Vietnam

Latin America

- Mexico

- Brazil

- Argentina

Middle East & Africa

- Turkey

- Saudi Arabia

- U.A.E

Global Indocyanine Green (CAS 3599-32-4) Market: Competitive Analysis

This section of the report identifies various key manufacturers of the market. It helps the reader understand the strategies and collaborations that players are focusing on combat competition in the market. The comprehensive report provides a significant microscopic look at the market. The reader can identify the footprints of the manufacturers by knowing about the global revenue of manufacturers, the global price of manufacturers, and sales by manufacturers during the forecast period of 2015 to 2019.

The major players in global Indocyanine Green (CAS 3599-32-4) market include:

- Akorn

- PULSION Medical Systems AG

- Diagnostic Green

- SERB

- Daiichi Sankyo Company

- Santen Pharmaceutical

- Aurolab

- Yichuang

- Eisai

Global Indocyanine Green (CAS 3599-32-4) Market Research Report 2020

Table of Contents
1 Indocyanine Green (CAS 3599-32-4) Market Overview
1.1 Product Overview and Scope of Indocyanine Green (CAS 3599-32-4)
1.2 Indocyanine Green (CAS 3599-32-4) Segment by Type
1.2.1 Global Indocyanine Green (CAS 3599-32-4) Sales Growth Rate Comparison by Type (2021-2026)
1.2.2 25mg
1.2.3 50mg
1.3 Indocyanine Green (CAS 3599-32-4) Segment by Application
1.3.1 Indocyanine Green (CAS 3599-32-4) Sales Comparison by Application: 2020 VS 2026
1.3.2 Ophthalmology
1.3.3 Neurosurgery
1.3.4 Liver Diseases
1.3.5 Others
1.4 Global Indocyanine Green (CAS 3599-32-4) Market Size Estimates and Forecasts
1.4.1 Global Indocyanine Green (CAS 3599-32-4) Revenue 2015-2026
1.4.2 Global Indocyanine Green (CAS 3599-32-4) Sales 2015-2026
1.4.3 Indocyanine Green (CAS 3599-32-4) Market Size by Region: 2020 Versus 2026
2 Global Indocyanine Green (CAS 3599-32-4) Market Competition by Manufacturers
2.1 Global Indocyanine Green (CAS 3599-32-4) Sales Market Share by Manufacturers (2015-2020)
2.2 Global Indocyanine Green (CAS 3599-32-4) Revenue Share by Manufacturers (2015-2020)
2.3 Global Indocyanine Green (CAS 3599-32-4) Average Price by Manufacturers (2015-2020)
2.4 Manufacturers Indocyanine Green (CAS 3599-32-4) Manufacturing Sites, Area Served, Product Type
2.5 Indocyanine Green (CAS 3599-32-4) Market Competitive Situation and Trends
2.5.1 Indocyanine Green (CAS 3599-32-4) Market Concentration Rate
2.5.2 Global Top 5 and Top 10 Players Market Share by Revenue
2.5.3 Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
2.7 Primary Interviews with Key Indocyanine Green (CAS 3599-32-4) Players (Opinion Leaders)
3 Indocyanine Green (CAS 3599-32-4) Retrospective Market Scenario by Region
3.1 Global Indocyanine Green (CAS 3599-32-4) Retrospective Market Scenario in Sales by Region: 2015-2020
3.2 Global Indocyanine Green (CAS 3599-32-4) Retrospective Market Scenario in Revenue by Region: 2015-2020
3.3 North America Indocyanine Green (CAS 3599-32-4) Market Facts & Figures by Country
3.3.1 North America Indocyanine Green (CAS 3599-32-4) Sales by Country
3.3.2 North America Indocyanine Green (CAS 3599-32-4) Sales by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Indocyanine Green (CAS 3599-32-4) Market Facts & Figures by Country
3.4.1 Europe Indocyanine Green (CAS 3599-32-4) Sales by Country
3.4.2 Europe Indocyanine Green (CAS 3599-32-4) Sales by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Indocyanine Green (CAS 3599-32-4) Market Facts & Figures by Region
3.5.1 Asia Pacific Indocyanine Green (CAS 3599-32-4) Sales by Region
3.5.2 Asia Pacific Indocyanine Green (CAS 3599-32-4) Sales by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Indocyanine Green (CAS 3599-32-4) Market Facts & Figures by Country
3.6.1 Latin America Indocyanine Green (CAS 3599-32-4) Sales by Country
3.6.2 Latin America Indocyanine Green (CAS 3599-32-4) Sales by Country
3.6.3 Mexico
3.6.3 Brazil
3.6.3 Argentina
3.7 Middle East and Africa Indocyanine Green (CAS 3599-32-4) Market Facts & Figures by Country
3.7.1 Middle East and Africa Indocyanine Green (CAS 3599-32-4) Sales by Country
3.7.2 Middle East and Africa Indocyanine Green (CAS 3599-32-4) Sales by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 U.A.E
4 Global Indocyanine Green (CAS 3599-32-4) Historic Market Analysis by Type
4.1 Global Indocyanine Green (CAS 3599-32-4) Sales Market Share by Type (2015-2020)
4.2 Global Indocyanine Green (CAS 3599-32-4) Revenue Market Share by Type (2015-2020)
4.3 Global Indocyanine Green (CAS 3599-32-4) Price Market Share by Type (2015-2020)
4.4 Global Indocyanine Green (CAS 3599-32-4) Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Global Indocyanine Green (CAS 3599-32-4) Historic Market Analysis by Application
5.1 Global Indocyanine Green (CAS 3599-32-4) Sales Market Share by Application (2015-2020)
5.2 Global Indocyanine Green (CAS 3599-32-4) Revenue Market Share by Application (2015-2020)
5.3 Global Indocyanine Green (CAS 3599-32-4) Price by Application (2015-2020)
6 Company Profiles and Key Figures in Indocyanine Green (CAS 3599-32-4) Business
6.1 Akorn
6.1.1 Corporation Information
6.1.2 Akorn Description, Business Overview and Total Revenue
6.1.3 Akorn Indocyanine Green (CAS 3599-32-4) Sales, Revenue and Gross Margin (2015-2020)
6.1.4 Akorn Products Offered
6.1.5 Akorn Recent Development
6.2 PULSION Medical Systems AG
6.2.1 PULSION Medical Systems AG Indocyanine Green (CAS 3599-32-4) Production Sites and Area Served
6.2.2 PULSION Medical Systems AG Description, Business Overview and Total Revenue
6.2.3 PULSION Medical Systems AG Indocyanine Green (CAS 3599-32-4) Sales, Revenue and Gross Margin (2015-2020)
6.2.4 PULSION Medical Systems AG Products Offered
6.2.5 PULSION Medical Systems AG Recent Development
6.3 Diagnostic Green
6.3.1 Diagnostic Green Indocyanine Green (CAS 3599-32-4) Production Sites and Area Served
6.3.2 Diagnostic Green Description, Business Overview and Total Revenue
6.3.3 Diagnostic Green Indocyanine Green (CAS 3599-32-4) Sales, Revenue and Gross Margin (2015-2020)
6.3.4 Diagnostic Green Products Offered
6.3.5 Diagnostic Green Recent Development
6.4 SERB
6.4.1 SERB Indocyanine Green (CAS 3599-32-4) Production Sites and Area Served
6.4.2 SERB Description, Business Overview and Total Revenue
6.4.3 SERB Indocyanine Green (CAS 3599-32-4) Sales, Revenue and Gross Margin (2015-2020)
6.4.4 SERB Products Offered
6.4.5 SERB Recent Development
6.5 Daiichi Sankyo Company
6.5.1 Daiichi Sankyo Company Indocyanine Green (CAS 3599-32-4) Production Sites and Area Served
6.5.2 Daiichi Sankyo Company Description, Business Overview and Total Revenue
6.5.3 Daiichi Sankyo Company Indocyanine Green (CAS 3599-32-4) Sales, Revenue and Gross Margin (2015-2020)
6.5.4 Daiichi Sankyo Company Products Offered
6.5.5 Daiichi Sankyo Company Recent Development
6.6 Santen Pharmaceutical
6.6.1 Santen Pharmaceutical Indocyanine Green (CAS 3599-32-4) Production Sites and Area Served
6.6.2 Santen Pharmaceutical Description, Business Overview and Total Revenue
6.6.3 Santen Pharmaceutical Indocyanine Green (CAS 3599-32-4) Sales, Revenue and Gross Margin (2015-2020)
6.6.4 Santen Pharmaceutical Products Offered
6.6.5 Santen Pharmaceutical Recent Development
6.7 Aurolab
6.6.1 Aurolab Indocyanine Green (CAS 3599-32-4) Production Sites and Area Served
6.6.2 Aurolab Description, Business Overview and Total Revenue
6.6.3 Aurolab Indocyanine Green (CAS 3599-32-4) Sales, Revenue and Gross Margin (2015-2020)
6.4.4 Aurolab Products Offered
6.7.5 Aurolab Recent Development
6.8 Yichuang
6.8.1 Yichuang Indocyanine Green (CAS 3599-32-4) Production Sites and Area Served
6.8.2 Yichuang Description, Business Overview and Total Revenue
6.8.3 Yichuang Indocyanine Green (CAS 3599-32-4) Sales, Revenue and Gross Margin (2015-2020)
6.8.4 Yichuang Products Offered
6.8.5 Yichuang Recent Development
6.9 Eisai
6.9.1 Eisai Indocyanine Green (CAS 3599-32-4) Production Sites and Area Served
6.9.2 Eisai Description, Business Overview and Total Revenue
6.9.3 Eisai Indocyanine Green (CAS 3599-32-4) Sales, Revenue and Gross Margin (2015-2020)
6.9.4 Eisai Products Offered
6.9.5 Eisai Recent Development
7 Indocyanine Green (CAS 3599-32-4) Manufacturing Cost Analysis
7.1 Indocyanine Green (CAS 3599-32-4) Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Raw Materials Price Trend
7.1.3 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Indocyanine Green (CAS 3599-32-4)
7.4 Indocyanine Green (CAS 3599-32-4) Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Indocyanine Green (CAS 3599-32-4) Distributors List
8.3 Indocyanine Green (CAS 3599-32-4) Customers
9 Market Dynamics
9.1 Market Trends
9.2 Opportunities and Drivers
9.3 Challenges
9.4 Porter's Five Forces Analysis
10 Global Market Forecast
10.1 Global Indocyanine Green (CAS 3599-32-4) Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Indocyanine Green (CAS 3599-32-4) by Type (2021-2026)
10.1.2 Global Forecasted Revenue of Indocyanine Green (CAS 3599-32-4) by Type (2021-2026)
10.2 Indocyanine Green (CAS 3599-32-4) Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Indocyanine Green (CAS 3599-32-4) by Application (2021-2026)
10.2.2 Global Forecasted Revenue of Indocyanine Green (CAS 3599-32-4) by Application (2021-2026)
10.3 Indocyanine Green (CAS 3599-32-4) Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Indocyanine Green (CAS 3599-32-4) by Region (2021-2026)
10.3.2 Global Forecasted Revenue of Indocyanine Green (CAS 3599-32-4) by Region (2021-2026)
10.4 North America Indocyanine Green (CAS 3599-32-4) Estimates and Projections (2021-2026)
10.5 Europe Indocyanine Green (CAS 3599-32-4) Estimates and Projections (2021-2026)
10.6 Asia Pacific Indocyanine Green (CAS 3599-32-4) Estimates and Projections (2021-2026)
10.7 Latin America Indocyanine Green (CAS 3599-32-4) Estimates and Projections (2021-2026)
10.8 Middle East and Africa Indocyanine Green (CAS 3599-32-4) Estimates and Projections (2021-2026)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
List of Tables
Table 1. Global Indocyanine Green (CAS 3599-32-4) Sales (K NOS) Growth Rate Comparison by Type (2015-2026)
Table 2. Global Indocyanine Green (CAS 3599-32-4) Sales (K NOS) Comparison by Application: 2020 VS 2026
Table 3. Global Indocyanine Green (CAS 3599-32-4) Market Size by Type (K NOS) (US$ Million) (2020 VS 2026)
Table 4. Global Key Indocyanine Green (CAS 3599-32-4) Manufacturers Covered in This Study
Table 5. Global Indocyanine Green (CAS 3599-32-4) Sales (K NOS) by Manufacturers (2015-2020)
Table 6. Global Indocyanine Green (CAS 3599-32-4) Sales Share by Manufacturers (2015-2020)
Table 7. Global Indocyanine Green (CAS 3599-32-4) Revenue (Million USD) by Manufacturers (2015-2020)
Table 8. Global Indocyanine Green (CAS 3599-32-4) Revenue Share by Manufacturers (2015-2020)
Table 9. Global Market Indocyanine Green (CAS 3599-32-4) Average Price (USD/NOS) of Key Manufacturers (2015-2020)
Table 10. Manufacturers Indocyanine Green (CAS 3599-32-4) Sales Sites and Area Served
Table 11. Manufacturers Indocyanine Green (CAS 3599-32-4) Product Types
Table 12. Global Indocyanine Green (CAS 3599-32-4) Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Indocyanine Green (CAS 3599-32-4) by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Indocyanine Green (CAS 3599-32-4) as of 2019)
Table 14.Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Main Points Interviewed from Key Indocyanine Green (CAS 3599-32-4) Players
Table 16. Global Indocyanine Green (CAS 3599-32-4) Sales (K NOS) by Region (2015-2020)
Table 17. Global Indocyanine Green (CAS 3599-32-4) Sales Market Share by Region (2015-2020)
Table 18. Global Indocyanine Green (CAS 3599-32-4) Revenue (Million US$) by Region (2015-2020)
Table 19. Global Indocyanine Green (CAS 3599-32-4) Revenue Market Share by Region (2015-2020)
Table 20. North America Indocyanine Green (CAS 3599-32-4) Sales by Country (2015-2020) (K NOS)
Table 21. North America Indocyanine Green (CAS 3599-32-4) Sales Market Share by Country (2015-2020)
Table 22. North America Indocyanine Green (CAS 3599-32-4) Revenue by Country (2015-2020) (US$ Million)
Table 23. North America Indocyanine Green (CAS 3599-32-4) Revenue Market Share by Country (2015-2020)
Table 24. Europe Indocyanine Green (CAS 3599-32-4) Sales by Country (2015-2020) (K NOS)
Table 25. Europe Indocyanine Green (CAS 3599-32-4) Sales Market Share by Country (2015-2020)
Table 26. Europe Indocyanine Green (CAS 3599-32-4) Revenue by Country (2015-2020) (US$ Million)
Table 27. Europe Indocyanine Green (CAS 3599-32-4) Revenue Market Share by Country (2015-2020)
Table 28. Asia Pacific Indocyanine Green (CAS 3599-32-4) Sales by Region (2015-2020) (K NOS)
Table 29. Asia Pacific Indocyanine Green (CAS 3599-32-4) Sales Market Share by Region (2015-2020)
Table 30. Asia Pacific Indocyanine Green (CAS 3599-32-4) Revenue by Region (2015-2020) (US$ Million)
Table 31. Asia Pacific Indocyanine Green (CAS 3599-32-4) Revenue Market Share by Region (2015-2020)
Table 32. Latin America Indocyanine Green (CAS 3599-32-4) Sales by Country (2015-2020) (K NOS)
Table 33. Latin America Indocyanine Green (CAS 3599-32-4) Sales Market Share by Country (2015-2020)
Table 34. Latin America Indocyanine Green (CAS 3599-32-4) Revenue by Country (2015-2020) (US$ Million)
Table 35. Latin America Indocyanine Green (CAS 3599-32-4) Revenue Market Share by Country (2015-2020)
Table 36. Middle East and Africa Indocyanine Green (CAS 3599-32-4) Sales by Country (2015-2020) (K NOS)
Table 37. Middle East and Africa Indocyanine Green (CAS 3599-32-4) Sales Market Share by Country (2015-2020)
Table 38. Middle East and Africa Indocyanine Green (CAS 3599-32-4) Revenue by Country (2015-2020) (US$ Million)
Table 39. Middle East and Africa Indocyanine Green (CAS 3599-32-4) Revenue Market Share by Country (2015-2020)
Table 40. Global Indocyanine Green (CAS 3599-32-4) Sales (K NOS) by Type (2015-2020)
Table 41. Global Indocyanine Green (CAS 3599-32-4) Sales Share by Type (2015-2020)
Table 42. Global Indocyanine Green (CAS 3599-32-4) Revenue (Million US$) by Type (2015-2020)
Table 43. Global Indocyanine Green (CAS 3599-32-4) Revenue Share by Type (2015-2020)
Table 44. Global Indocyanine Green (CAS 3599-32-4) Price (USD/NOS) by Type (2015-2020)
Table 45. Global Indocyanine Green (CAS 3599-32-4) Sales (K NOS) by Application (2015-2020)
Table 46. Global Indocyanine Green (CAS 3599-32-4) Sales Market Share by Application (2015-2020)
Table 47. Global Indocyanine Green (CAS 3599-32-4) Sales Growth Rate by Application (2015-2020)
Table 48. Akorn Indocyanine Green (CAS 3599-32-4) Corporation Information
Table 49. Akorn Description and Business Overview
Table 50. Akorn Indocyanine Green (CAS 3599-32-4) Sales (K NOS), Revenue (Million US$), Price (USD/NOS) and Gross Margin (2015-2020)
Table 51. Akorn Main Product
Table 52. Akorn Recent Development
Table 53. PULSION Medical Systems AG Indocyanine Green (CAS 3599-32-4) Corporation Information
Table 54. PULSION Medical Systems AG Corporation Information
Table 55. PULSION Medical Systems AG Indocyanine Green (CAS 3599-32-4) Sales (K NOS), Revenue (Million US$), Price (USD/NOS) and Gross Margin (2015-2020)
Table 56. PULSION Medical Systems AG Main Product
Table 57. PULSION Medical Systems AG Recent Development
Table 58. Diagnostic Green Indocyanine Green (CAS 3599-32-4) Corporation Information
Table 59. Diagnostic Green Corporation Information
Table 60. Diagnostic Green Indocyanine Green (CAS 3599-32-4) Sales (K NOS), Revenue (Million US$), Price (USD/NOS) and Gross Margin (2015-2020)
Table 61. Diagnostic Green Main Product
Table 62. Diagnostic Green Recent Development
Table 63. SERB Indocyanine Green (CAS 3599-32-4) Corporation Information
Table 64. SERB Corporation Information
Table 65. SERB Indocyanine Green (CAS 3599-32-4) Sales (K NOS), Revenue (Million US$), Price (USD/NOS) and Gross Margin (2015-2020)
Table 66. SERB Main Product
Table 67. SERB Recent Development
Table 68. Daiichi Sankyo Company Indocyanine Green (CAS 3599-32-4) Corporation Information
Table 69. Daiichi Sankyo Company Corporation Information
Table 70. Daiichi Sankyo Company Indocyanine Green (CAS 3599-32-4) Sales (K NOS), Revenue (Million US$), Price (USD/NOS) and Gross Margin (2015-2020)
Table 71. Daiichi Sankyo Company Main Product
Table 72. Daiichi Sankyo Company Recent Development
Table 73. Santen Pharmaceutical Indocyanine Green (CAS 3599-32-4) Corporation Information
Table 74. Santen Pharmaceutical Corporation Information
Table 75. Santen Pharmaceutical Indocyanine Green (CAS 3599-32-4) Sales (K NOS), Revenue (Million US$), Price (USD/NOS) and Gross Margin (2015-2020)
Table 76. Santen Pharmaceutical Main Product
Table 77. Santen Pharmaceutical Recent Development
Table 78. Aurolab Indocyanine Green (CAS 3599-32-4) Corporation Information
Table 79. Aurolab Corporation Information
Table 80. Aurolab Indocyanine Green (CAS 3599-32-4) Sales (K NOS), Revenue (Million US$), Price (USD/NOS) and Gross Margin (2015-2020)
Table 81. Aurolab Main Product
Table 82. Aurolab Recent Development
Table 83. Yichuang Indocyanine Green (CAS 3599-32-4) Corporation Information
Table 84. Yichuang Corporation Information
Table 85. Yichuang Indocyanine Green (CAS 3599-32-4) Sales (K NOS), Revenue (Million US$), Price (USD/NOS) and Gross Margin (2015-2020)
Table 86. Yichuang Main Product
Table 87. Yichuang Recent Development
Table 88. Eisai Indocyanine Green (CAS 3599-32-4) Corporation Information
Table 89. Eisai Corporation Information
Table 90. Eisai Indocyanine Green (CAS 3599-32-4) Sales (K NOS), Revenue (Million US$), Price (USD/NOS) and Gross Margin (2015-2020)
Table 91. Eisai Main Product
Table 92. Eisai Recent Development
Table 93. Sales Base and Market Concentration Rate of Raw Material
Table 94. Key Suppliers of Raw Materials
Table 95. Indocyanine Green (CAS 3599-32-4) Distributors List
Table 96. Indocyanine Green (CAS 3599-32-4) Customers List
Table 97. Market Key Trends
Table 98. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 99. Key Challenges
Table 100. Global Indocyanine Green (CAS 3599-32-4) Sales (K NOS) Forecast by Type (2021-2026)
Table 101. Global Indocyanine Green (CAS 3599-32-4) Sales Market Share Forecast by Type (2021-2026)
Table 102. Global Indocyanine Green (CAS 3599-32-4) Revenue (Million US$) Forecast by Type (2021-2026)
Table 103. Global Indocyanine Green (CAS 3599-32-4) Revenue (Million US$) Market Share Forecast by Type (2021-2026)
Table 104. Global Indocyanine Green (CAS 3599-32-4) Sales (K NOS) Forecast by Application (2021-2026)
Table 105. Global Indocyanine Green (CAS 3599-32-4) Revenue (Million US$) Forecast by Application (2021-2026)
Table 106. Global Indocyanine Green (CAS 3599-32-4) Sales (K NOS) Forecast by Region (2021-2026)
Table 107. Global Indocyanine Green (CAS 3599-32-4) Sales Market Share Forecast by Region (2021-2026)
Table 108. Global Indocyanine Green (CAS 3599-32-4) Revenue Forecast by Region (2021-2026) (US$ Million)
Table 109. Global Indocyanine Green (CAS 3599-32-4) Revenue Market Share Forecast by Region (2021-2026)
Table 110. Research Programs/Design for This Report
Table 111. Key Data Information from Secondary Sources
Table 112. Key Data Information from Primary Sources
List of Figures
Figure 1. Picture of Indocyanine Green (CAS 3599-32-4)
Figure 2. Global Indocyanine Green (CAS 3599-32-4) Sales Market Share by Type: 2020 VS 2026
Figure 3. 25mg Product Picture
Figure 4. 50mg Product Picture
Figure 5. Global Indocyanine Green (CAS 3599-32-4) Consumption Market Share by Application: 2020 VS 2026
Figure 6. Ophthalmology
Figure 7. Neurosurgery
Figure 8. Liver Diseases
Figure 9. Others
Figure 10. Global Indocyanine Green (CAS 3599-32-4) Market Size 2015-2026 (US$ Million)
Figure 11. Global Indocyanine Green (CAS 3599-32-4) Sales Capacity (K NOS) (2015-2026)
Figure 12. Global Indocyanine Green (CAS 3599-32-4) Market Size Market Share by Region: 2020 Versus 2026
Figure 13. Indocyanine Green (CAS 3599-32-4) Sales Share by Manufacturers in 2020
Figure 14. Global Indocyanine Green (CAS 3599-32-4) Revenue Share by Manufacturers in 2019
Figure 15. The Global 5 and 10 Largest Players: Market Share by Indocyanine Green (CAS 3599-32-4) Revenue in 2019
Figure 16. Indocyanine Green (CAS 3599-32-4) Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 17. Global Indocyanine Green (CAS 3599-32-4) Sales Market Share by Region (2015-2020)
Figure 18. Global Indocyanine Green (CAS 3599-32-4) Sales Market Share by Region in 2019
Figure 19. Global Indocyanine Green (CAS 3599-32-4) Revenue Market Share by Region (2015-2020)
Figure 20. Global Indocyanine Green (CAS 3599-32-4) Revenue Market Share by Region in 2019
Figure 21. North America Indocyanine Green (CAS 3599-32-4) Sales Market Share by Country in 2019
Figure 22. North America Indocyanine Green (CAS 3599-32-4) Revenue Market Share by Country in 2019
Figure 23. U.S. Indocyanine Green (CAS 3599-32-4) Sales Growth Rate (2015-2020) (K NOS)
Figure 24. U.S. Indocyanine Green (CAS 3599-32-4) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 25. Canada Indocyanine Green (CAS 3599-32-4) Sales Growth Rate (2015-2020) (K NOS)
Figure 26. Canada Indocyanine Green (CAS 3599-32-4) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 27. Europe Indocyanine Green (CAS 3599-32-4) Sales Market Share by Country in 2019
Figure 28. Europe Indocyanine Green (CAS 3599-32-4) Revenue Market Share by Country in 2019
Figure 29. Germany Indocyanine Green (CAS 3599-32-4) Sales Growth Rate (2015-2020) (K NOS)
Figure 30. Germany Indocyanine Green (CAS 3599-32-4) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 31. France Indocyanine Green (CAS 3599-32-4) Sales Growth Rate (2015-2020) (K NOS)
Figure 32. France Indocyanine Green (CAS 3599-32-4) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 33. U.K. Indocyanine Green (CAS 3599-32-4) Sales Growth Rate (2015-2020) (K NOS)
Figure 34. U.K. Indocyanine Green (CAS 3599-32-4) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 35. Italy Indocyanine Green (CAS 3599-32-4) Sales Growth Rate (2015-2020) (K NOS)
Figure 36. Italy Indocyanine Green (CAS 3599-32-4) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 37. Russia Indocyanine Green (CAS 3599-32-4) Sales Growth Rate (2015-2020) (K NOS)
Figure 38. Russia Indocyanine Green (CAS 3599-32-4) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 39. Asia Pacific Indocyanine Green (CAS 3599-32-4) Sales Market Share by Region in 2019
Figure 40. Asia Pacific Indocyanine Green (CAS 3599-32-4) Revenue Market Share by Region in 2019
Figure 41. China Indocyanine Green (CAS 3599-32-4) Sales Growth Rate (2015-2020) (K NOS)
Figure 42. China Indocyanine Green (CAS 3599-32-4) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 43. Japan Indocyanine Green (CAS 3599-32-4) Sales Growth Rate (2015-2020) (K NOS)
Figure 44. Japan Indocyanine Green (CAS 3599-32-4) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 45. South Korea Indocyanine Green (CAS 3599-32-4) Sales Growth Rate (2015-2020) (K NOS)
Figure 46. South Korea Indocyanine Green (CAS 3599-32-4) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 47. India Indocyanine Green (CAS 3599-32-4) Sales Growth Rate (2015-2020) (K NOS)
Figure 48. India Indocyanine Green (CAS 3599-32-4) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 49. Australia Indocyanine Green (CAS 3599-32-4) Sales Growth Rate (2015-2020) (K NOS)
Figure 50. Australia Indocyanine Green (CAS 3599-32-4) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 51. Taiwan Indocyanine Green (CAS 3599-32-4) Sales Growth Rate (2015-2020) (K NOS)
Figure 52. Taiwan Indocyanine Green (CAS 3599-32-4) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 53. Indonesia Indocyanine Green (CAS 3599-32-4) Sales Growth Rate (2015-2020) (K NOS)
Figure 54. Indonesia Indocyanine Green (CAS 3599-32-4) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 55. Thailand Indocyanine Green (CAS 3599-32-4) Sales Growth Rate (2015-2020) (K NOS)
Figure 56. Thailand Indocyanine Green (CAS 3599-32-4) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 57. Malaysia Indocyanine Green (CAS 3599-32-4) Sales Growth Rate (2015-2020) (K NOS)
Figure 58. Malaysia Indocyanine Green (CAS 3599-32-4) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 59. Philippines Indocyanine Green (CAS 3599-32-4) Sales Growth Rate (2015-2020) (K NOS)
Figure 60. Philippines Indocyanine Green (CAS 3599-32-4) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 61. Vietnam Indocyanine Green (CAS 3599-32-4) Sales Growth Rate (2015-2020) (K NOS)
Figure 62. Vietnam Indocyanine Green (CAS 3599-32-4) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 63. Latin America Indocyanine Green (CAS 3599-32-4) Sales Market Share by Country in 2019
Figure 64. Latin America Indocyanine Green (CAS 3599-32-4) Revenue Market Share by Country in 2019
Figure 65. Mexico Indocyanine Green (CAS 3599-32-4) Sales Growth Rate (2015-2020) (K NOS)
Figure 66. Mexico Indocyanine Green (CAS 3599-32-4) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 67. Brazil Indocyanine Green (CAS 3599-32-4) Sales Growth Rate (2015-2020) (K NOS)
Figure 68. Brazil Indocyanine Green (CAS 3599-32-4) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 69. Argentina Indocyanine Green (CAS 3599-32-4) Sales Growth Rate (2015-2020) (K NOS)
Figure 70. Argentina Indocyanine Green (CAS 3599-32-4) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 71. Middle East and Africa Indocyanine Green (CAS 3599-32-4) Sales Market Share by Country in 2019
Figure 72. Middle East and Africa Indocyanine Green (CAS 3599-32-4) Revenue Market Share by Country in 2019
Figure 73. Turkey Indocyanine Green (CAS 3599-32-4) Sales Growth Rate (2015-2020) (K NOS)
Figure 74. Turkey Indocyanine Green (CAS 3599-32-4) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 75. Saudi Arabia Indocyanine Green (CAS 3599-32-4) Sales Growth Rate (2015-2020) (K NOS)
Figure 76. Saudi Arabia Indocyanine Green (CAS 3599-32-4) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 77. U.A.E Indocyanine Green (CAS 3599-32-4) Sales Growth Rate (2015-2020) (K NOS)
Figure 78. U.A.E Indocyanine Green (CAS 3599-32-4) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 79. Sales Market Share of Indocyanine Green (CAS 3599-32-4) by Type (2015-2020)
Figure 80. Sales Market Share of Indocyanine Green (CAS 3599-32-4) by Type in 2019
Figure 81. Revenue Share of Indocyanine Green (CAS 3599-32-4) by Type (2015-2020)
Figure 82. Revenue Market Share of Indocyanine Green (CAS 3599-32-4) by Type in 2019
Figure 83. Global Indocyanine Green (CAS 3599-32-4) Sales Growth by Type (2015-2020) (K NOS)
Figure 84. Global Indocyanine Green (CAS 3599-32-4) Sales Market Share by Application (2015-2020)
Figure 85. Global Indocyanine Green (CAS 3599-32-4) Sales Market Share by Application in 2019
Figure 86. Global Revenue Share of Indocyanine Green (CAS 3599-32-4) by Application (2015-2020)
Figure 87. Global Revenue Share of Indocyanine Green (CAS 3599-32-4) by Application in 2020
Figure 88. Akorn Total Revenue (US$ Million): 2019 Compared with 2018
Figure 89. PULSION Medical Systems AG Total Revenue (US$ Million): 2019 Compared with 2018
Figure 90. Diagnostic Green Total Revenue (US$ Million): 2019 Compared with 2018
Figure 91. SERB Total Revenue (US$ Million): 2019 Compared with 2018
Figure 92. Daiichi Sankyo Company Total Revenue (US$ Million): 2019 Compared with 2018
Figure 93. Santen Pharmaceutical Total Revenue (US$ Million): 2019 Compared with 2018
Figure 94. Aurolab Total Revenue (US$ Million): 2019 Compared with 2018
Figure 95. Yichuang Total Revenue (US$ Million): 2019 Compared with 2018
Figure 96. Eisai Total Revenue (US$ Million): 2019 Compared with 2018
Figure 97. Price Trend of Key Raw Materials
Figure 98. Manufacturing Cost Structure of Indocyanine Green (CAS 3599-32-4)
Figure 99. Manufacturing Process Analysis of Indocyanine Green (CAS 3599-32-4)
Figure 100. Indocyanine Green (CAS 3599-32-4) Industrial Chain Analysis
Figure 101. Channels of Distribution
Figure 102. Distributors Profiles
Figure 103. Porter's Five Forces Analysis
Figure 104. North America Indocyanine Green (CAS 3599-32-4) Sales (K NOS) and Growth Rate Forecast (2021-2026)
Figure 105. North America Indocyanine Green (CAS 3599-32-4) Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 106. Europe Indocyanine Green (CAS 3599-32-4) Sales (K NOS) and Growth Rate Forecast (2021-2026)
Figure 107. Europe Indocyanine Green (CAS 3599-32-4) Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 108. Latin America Indocyanine Green (CAS 3599-32-4) Sales (K NOS) and Growth Rate Forecast (2021-2026)
Figure 109. Latin America Indocyanine Green (CAS 3599-32-4) Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 110. Middle East and Africa Indocyanine Green (CAS 3599-32-4) Sales (K NOS) and Growth Rate Forecast (2021-2026)
Figure 111. Middle East and Africa Indocyanine Green (CAS 3599-32-4) Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 112. Asia Pacific Indocyanine Green (CAS 3599-32-4) Sales (K NOS) and Growth Rate Forecast (2021-2026)
Figure 113. Asia Pacific Indocyanine Green (CAS 3599-32-4) Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 114. Bottom-up and Top-down Approaches for This Report
Figure 115. Data Triangulation
Figure 116. Key Executives Interviewed
  • Global Histone Deacetylase (HDAC) Inhibitors Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 87
    The global Histone Deacetylase (HDAC) Inhibitors market was valued at US$ 615.2 million in 2023 and is anticipated to reach US$ 1223.2 million by 2030, witnessing a CAGR of 8.8% during The forecast period 2024-2030. North American market for Histone Deacetylase (HDAC) Inhibitors is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Histone Deacetylase (HDAC) Inhibitor......
  • Global Esomeprazole Magnesium Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 74
    The global Esomeprazole Magnesium market was valued at US$ 5287 million in 2023 and is anticipated to reach US$ 9451.5 million by 2030, witnessing a CAGR of 8.3% during The forecast period 2024-2030. North American market for Esomeprazole Magnesium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Esomeprazole Magnesium is estimated to increase from $ million in 2......
  • Global Combination Therapy Drug Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86
    The global Combination Therapy Drug market was valued at US$ 105 million in 2023 and is anticipated to reach US$ 166.7 million by 2030, witnessing a CAGR of 4.1% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is......
  • Global Axitinib Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 68
    The global Axitinib market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Axitinib is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Axitinib is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The......
  • Global Lyme Disease Vaccine Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 70
    The lyme disease vaccine can reduce lyme disease incidence, reduce symptoms and reduce mortality. Lyme disease is a tick-borne infection of spirochete, a natural disease caused by borrelia burgdorferi. The global Lyme Disease Vaccine market was valued at US$ 257 million in 2023 and is anticipated to reach US$ 763 million by 2030, witnessing a CAGR of 8.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at......
  • Global Transdermal Absorption Patch Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Transdermal Absorption Patch market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Transdermal Absorption Patch is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Transdermal Absorption Patch is estimated to increase from $ million i......
  • Global Ketoprofen Patches Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78
    Ketoprofen patch, indications for The treatment of symptoms caused by The following diseases: rheumatoid arthritis and rheumatoid arthritis The global Ketoprofen Patches market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Ketoprofen Patches is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast per......
  • Global Methyl Salicylate Patches Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 82
    The global Methyl Salicylate Patches market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Methyl Salicylate Patches is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Methyl Salicylate Patches is estimated to increase from $ million in 2023 to......
  • Global Diclofenac Patches Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94
    The global Diclofenac Patches market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Diclofenac Patches is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Diclofenac Patches is estimated to increase from $ million in 2023 to reach $ million by 2......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs